It has been shown that C3 promotes ovarian cancer cell proliferation by activating the C3a-C3aR-PI3K-AKT signaling pathway [22], and the PI3K/AKT pathway is a key link to modulate drug resistance [40]. This evidence concerns the gene C3AR1 and ovarian cancer.